Precision Neuroscience

Precision Neuroscience

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.precisionneuro.io

Last Round

VC Round

Nov 5, 2025

Est. Valuation

$500M

Total Funding Raised

$155M

Company Overview

Precision Neuroscience is a neurotechnology company that develops minimally invasive brain-computer interface technology aimed at delivering effective treatments for patients with neurological disorders by facilitating direct connections between the human brain and artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Sensors, Semiconductors, Computing Hardware, Clinical Trials

Business Model

B2B2C

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

brain-computer interfaceBCIneural implantbrain implantbrain chipminimally invasive BCIcortical interfaceneurotechnologyparalysis treatmentmicroelectrode arrayassistive technologyneural decodingreversible implantbrain mappingspinal cord injurystroke recoveryALS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Precision Neuroscience Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Precision Neuroscience Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 5, 2025
Series CDec 16, 2024
Series BJan 25, 2023
Series AMay 25, 2021

Key People

Founding team and executive leadership

Benjamin Rapoport

Co-Founder And Chief Science Officer

Founding Team

Michael Mager

Co-Founder And Chief Executive Officer

Founding Team

Craig Mermel

President And Chief Product Officer

Executive Team

Nathan Pletcher

Chief Technology Officer

Executive Team

Precision Neuroscience Investors

Notable investors and investment history

InvestorRounds
Forepont Capital PartnersSeries B
Steadview CapitalSeries B, Series C, Series A
SCI VenturesVC Round
B Capital GroupSeries B, Series C, Series A
Duquesne Family OfficeSeries C
re.Mind CapitalSeries B
General Equity HoldingsSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 4, 2026

    First product, the Layer 7 brain-computer interface, has begun human trials.

  • Feb 11, 2026

    Integrating electrode technology with Medtronic's navigation platform for synchronized brain data.

Precision Neuroscience Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Precision Neuroscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Precision Neuroscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range117
Year Founded2021
Last FundingNov 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.